Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study

Marcus Karl-Heinz Auth; James John Ashton; Kelsey D J Jones; Astor Rodrigues; Dhamyanthi Thangarajah; David Devadason; Gemma Lee; Mashhood Ayaz; Huey Miin Lee; Jochen Kammermeier

doi:10.1136/archdischild-2022-325236

Article info

Original research

Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study

Authors

Marcus Karl-Heinz Auth Department of Paediatric Gastroenterology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK PubMed articles Google scholar articles
James John Ashton Department of Paediatric Gastroenterology, Southampton Children’s Hospital, Southampton, UK Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK PubMed articles Google scholar articles
Kelsey D J Jones Department of Paediatric Gastroenterology, Great Ormond Street Hospital, London, UK Department of Paediatric Gastroenterology, University of Oxford, Oxford, UK PubMed articles Google scholar articles
Astor Rodrigues Paediatric Gastroenterology, John Radcliffe Hospital, Oxford, UK PubMed articles Google scholar articles
Dhamyanthi Thangarajah Department of Paediatric Gastroenterology, Chelsea and Westminster Hospital, London, UK PubMed articles Google scholar articles
David Devadason Paediatric Gastroenterology, Nottingham Children's Hospital, Nottingham, UK PubMed articles Google scholar articles
Gemma Lee Department of Paediatric Gastroenterology, Evelina London Children’s Hospital, London, UK PubMed articles Google scholar articles
Mashhood Ayaz Paediatric Gastroenterology, Epsom and Saint Helier University Hospitals NHS Trust, Carshalton, UK PubMed articles Google scholar articles
Huey Miin Lee Department of Paediatric Gastroenterology, King’s College Hospital, London, UK PubMed articles Google scholar articles
Jochen Kammermeier Department of Paediatric Gastroenterology, Evelina London Children’s Hospital, London, UK PubMed articles Google scholar articles
BSPGHAN IBD Biologics Survey Contributors
Google scholar articles

Correspondence to Dr Marcus Karl-Heinz Auth, Department of Paediatric Gastroenterology, Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP, UK; marcus.auth{at}alderhey.nhs.uk

View Full Text

Citation

Auth MK, Ashton JJ, Jones KDJ BSPGHAN IBD Biologics Survey Contributors, et al

Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study

Archives of Disease in Childhood 2023;108:994-998.

Publication history

Received December 13, 2022
Accepted July 20, 2023
First published August 4, 2023.

Online issue publication

November 17, 2023

Article Versions

Previous version (4 August 2023).
Previous version (24 October 2023).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password